Third-Party Natural Killer Cells and Mogamulizumab for the Treatment of Relapsed or Refractory Cutaneous T-cell Lymphomas or Adult T-Cell Leukemia/Lymphoma

Name: Third-Party Natural Killer Cells and Mogamulizumab for the Treatment of Relapsed or Refractory Cutaneous T-cell Lymphomas or Adult T-Cell Leukemia/Lymphoma
License: Public Domain

John Reneau

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

recurrent adult t-cell leukemia/lymphoma, recurrent primary cutaneous t-cell non-hodgkin lymphoma, refractory adult t-cell leukemia/lymphoma, refractory primary cutaneous t-cell non-hodgkin lymphoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 172309
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.